<DOC>
	<DOCNO>NCT00861796</DOCNO>
	<brief_summary>This Phase II study test whether CYR-101 , CNS-active compound novel pharmacological profile devoid dopamine D2 receptor binding property , efficacious administer orally management patient diagnosis DSM-IV schizophrenia .</brief_summary>
	<brief_title>Study CYR-101 Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Male female patient , 18 65 year age , inclusive Female patient must test negative pregnancy , childbearing potential , must use medically accept mean contraception . Patients must diagnosis Schizophrenia schizoaffective disorder define Diagnostic Statistical Manual Mental Disorders , Fourth Edition Text Revised ( DSMIV TR , APA 2000 ) ( Disorganised , 295.10 ; Catatonic , 295.20 ; Paranoid , 295.30 ; Residual , 295.60 ; Undifferentiated , 295.90 ) confirm Structured Clinical Interview DSMIV ( SCID ) . Patients must meet follow psychopathologic severity criterion screen : Positive Negative Syndrome Scale ( PANSS ) total score , least 60 . Patients must receive rating 4 ( moderately ill ) great Clinical Global ImpressionSeverity ( CGIS ) scale screen . Patients , opinion investigator , switch another antipsychotic medication initiation antipsychotic medication indicate . Patients must consider reliable , level understanding sufficient perform test examination require protocol . Patients must able understand nature study give informed consent . Are investigator site personnel directly affiliate study , immediate family investigator site personnel directly affiliate study . Immediate family define spouse , parent , child , sibling , whether biological legally adopt . Have receive treatment drug receive regulatory approval indication within 30 day prior screen . Patients treatment CYR101 , placebo , specify protocol , relatively absolutely clinically contraindicate . Patients history inadequate response , opinion investigator , 2 adequate antipsychotic medication trial least 8 week duration past 12 month prior screen . Patients require concomitant treatment medication primary central nervous system activity , certain allow medication specify Study Protocol . Patients receive treatment depot antipsychotic medication within 1 dose interval , minimum 4 week , prior screen . Actively suicidal ( example suicide attempt within past month current suicidal intent include plan ) opinion investigator score 4 great Item 10 MontgomeryAsberg Depression Rating Scale ( MADRS ) . DSMIV diagnosis substance dependence substance abuse ( except nicotine caffeine ) within 6 month prior screen . Diagnosis substanceinduced psychosis DSMIV criterion within 7 day screen ( time study ) . Patients current heteroaggressive behavior . Female patient pregnant , nursing , intend become pregnant within 30 day complete study . Have increase risk seizure evidence history : one seizure ( except childhood febrile seizure ) , history electroencephalogram ( EEG ) epileptiform activity , history stroke ; surgery cerebral cortex ; head trauma loss consciousness . NOTE : patient history childhood febrile seizure may enrol study . Patients electroconvulsive therapy ( ECT ) within 3 month screen visit ECT time study . Test HIV positive . Test positive Hepatitis C antibody Hepatitis B surface antigen ( HBsAg ) . Patients positive Hepatitis B core antibody test negative HBsAg may include study aminotransferase level ( ALT/SGPT AST/SGOT ) exceed 1.5 time upper limit normal ( ULN ) . Alanine transaminase/serum glutamicpyruvic transaminase ( ALT/SGPT ) value &gt; 1.5 time ULN perform laboratory , total bilirubin value &gt; 2 time ULN concomitant ALT/SGPT value &gt; 1.5 time ULN total bilirubin value &gt; 1.5 time ULN screening . Patients acute , serious , unstable medical condition , include ( limited ) inadequately control diabetes ( hemoglobin A1c ( HbA1c ) &gt; 8 % ) , severe hypertriglyceridemia ( fast triglyceride &gt; 5.6 mmol/L , recent cerebrovascular accident , serious acute systemic infection immunologic disease , unstable cardiovascular disorder ( include ischemic heart disease ) , malnutrition , hepatic , renal , gastroenterologic , respiratory , endocrinologic , neurologic , haematologic disease . Prolactin level screen visit great 200 ng/mL ( 200mg/L ) . A diagnosis Parkinson 's disease , dementiarelated psychosis , related disorder . If patient past misdiagnosis Parkinson 's disease , dementiarelated psychosis , related disorder , investigator need contact Clinical Research Physician prior enrolment . Patient current clinically significant cardiovascular disease . History syncopal event due cardiovascular abnormality .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>